Folger Nolan Fleming Douglas Capital Management, Inc Eli Lilly & CO Transaction History

Folger Nolan Fleming Douglas Capital Management, Inc

$889 Million
Q2 2024

A detailed history of Folger Nolan Fleming Douglas Capital Management, Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Folger Nolan Fleming Douglas Capital Management, Inc holds 5,171 shares of LLY stock, worth $4.67 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares

5,171

Previous 5,206 0.67%

Holding current value

$4.67 Million

Previous $4.05 Million 15.58%

% of portfolio

0.53%

Previous 0.45%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 09, 2024	SELL	$724.87 - $909.04 $25,370 - $31,816	-35 Reduced 0.67%	5,171 $4.68 Million
Q1 2024 Apr 12, 2024	SELL	$592.2 - $792.28 $5,922 - $7,922	-10 Reduced 0.19%	5,206 $4.05 Million
Q4 2023 Feb 05, 2024	SELL	$525.19 - $619.13 $26,259 - $30,956	-50 Reduced 0.95%	5,216 $3.04 Million
Q3 2023 Oct 25, 2023	SELL	$434.7 - $599.3 $21,735 - $29,964	-50 Reduced 0.94%	5,266 $2.83 Million
Q2 2023 Jul 27, 2023	SELL	$350.74 - $468.98 $2,104 - $2,813	-6 Reduced 0.11%	5,316 $2.49 Million
Q4 2022 Jan 30, 2023	BUY	$321.55 - $374.67 $160,775 - $187,335	500 Added 10.37%	5,322 $1.95 Million
Q1 2020 May 06, 2020	SELL	$119.05 - $147.35 $1,309 - $1,620	-11 Reduced 0.23%	4,822 $669,000
Q3 2019 Nov 08, 2019	BUY	$106.79 - $116.16 $1,174 - $1,277	11 Added 0.23%	4,833 $540,000
Q4 2018 Feb 12, 2019	BUY	$105.9 - $118.64 $451,557 - $505,880	4,264 Added 764.16%	4,822 $558,000
Q4 2018 Feb 11, 2019	SELL	$105.9 - $118.64 $451,557 - $505,880	-4,264 Reduced 88.43%	558 $558,000
Q4 2017 Feb 12, 2018	BUY	$81.94 - $87.89 $61,946 - $66,444	756 Added 18.59%	4,822 $407,000
Q2 2017 Aug 11, 2017	BUY	N/A	4,066	4,066 $335,000

Others Institutions Holding LLY

# of Institutions

3,865

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $858B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Folger Nolan Fleming Douglas Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Folger Nolan Fleming Douglas Capital Management, Inc with notifications on news.

Account

Folger Nolan Fleming Douglas Capital Management, Inc Eli Lilly & CO Transaction History